The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy.
D000163:Acquired Immunodeficiency Syndrome; D003256:Community Participation; D003657:Decision Making; D004345:Drug Industry; D015507:Drugs, Investigational; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006679:HIV Seropositivity; D015276:Health Care Rationing; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D005791:Patient Care; D010358:Patient Participation; D018579:Patient Selection; D010361:Patients; D004364:Pharmaceutical Preparations; D010919:Placebos; D011057:Politics; D011203:Poverty; D011640:Public Policy; D011897:Random Allocation; D012015:Reference Standards; D012106:Research; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine
Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach; Professional Patient Relationship